TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
SRZN Stock 12 Month Forecast
Average Price Target
$36.67
▲(68.52% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Surrozen in the last 3 months. The average price target is $36.67 with a high forecast of $42.00 and a low forecast of $32.00. The average price target represents a 68.52% change from the last price of $21.76.
Surrozen's Innovative Wnt Pathway Advancements in Retinal Disease Treatment Earns Buy RatingValuation and Risks. We reiterate our Buy rating and $32 price target. Our price target of $32 per share is based on an equally- weighted composite of: (a) $46.41 per share, as a 25x multiple of taxed and diluted 2036 EPS of $7.12 discounted back to and (b) an NPV discounted cash flow between 2025-2036 of $16.64 per share, with a discount rate of 13% and growth rate of 1%. These assumptions are in-line with the expected P/E multiple and discount rates of a developmental- stage biopharmaceutical company.
Unknown Analyst
Guggenheim
Not Ranked
Guggenheim
$42
Buy
93.01%
Upside
Reiterated
11/09/25
Surrozen (SRZN) Receives a Buy from Guggenheim
Unknown Analyst
Guggenheim
Not Ranked
Guggenheim
$42
Buy
93.01%
Upside
Reiterated
08/11/25
Guggenheim Keeps Their Buy Rating on Surrozen (SRZN)
Surrozen's Innovative Wnt Pathway Advancements in Retinal Disease Treatment Earns Buy RatingValuation and Risks. We reiterate our Buy rating and $32 price target. Our price target of $32 per share is based on an equally- weighted composite of: (a) $46.41 per share, as a 25x multiple of taxed and diluted 2036 EPS of $7.12 discounted back to and (b) an NPV discounted cash flow between 2025-2036 of $16.64 per share, with a discount rate of 13% and growth rate of 1%. These assumptions are in-line with the expected P/E multiple and discount rates of a developmental- stage biopharmaceutical company.
Unknown Analyst
Guggenheim
Not Ranked
Guggenheim
$42
Buy
93.01%
Upside
Reiterated
11/09/25
Surrozen (SRZN) Receives a Buy from Guggenheim
Unknown Analyst
Guggenheim
Not Ranked
Guggenheim
$42
Buy
93.01%
Upside
Reiterated
08/11/25
Guggenheim Keeps Their Buy Rating on Surrozen (SRZN)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +23.57% per trade.
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +31.18% per trade.
Copying Matthew Caufield's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +103.85% per trade.
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +103.85% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
SRZN Analyst Recommendation Trends
Rating
Apr 25
May 25
Aug 25
Sep 25
Nov 25
Strong Buy
3
4
4
4
4
Buy
0
0
0
0
0
Hold
4
4
2
0
0
Sell
4
1
1
0
0
Strong Sell
0
0
0
0
0
total
11
9
7
4
4
In the current month, SRZN has received 4Buy Ratings, 0Hold Ratings, and 0Sell Ratings. SRZN average Analyst price target in the past 3 months is 36.67.
Each month's total comprises the sum of three months' worth of ratings.
SRZN Financial Forecast
SRZN Earnings Forecast
Next quarter’s earnings estimate for SRZN is -$1.30 with a range of -$1.59 to -$1.09. The previous quarter’s EPS was -$8.36. SRZN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year SRZN has Performed in-line its overall industry.
Next quarter’s earnings estimate for SRZN is -$1.30 with a range of -$1.59 to -$1.09. The previous quarter’s EPS was -$8.36. SRZN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year SRZN has Performed in-line its overall industry.
SRZN Sales Forecast
Next quarter’s sales forecast for SRZN is $500.00K with a range of $0.00 to $1.00M. The previous quarter’s sales results were $983.00K. SRZN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year SRZN has Performed in-line its overall industry.
Next quarter’s sales forecast for SRZN is $500.00K with a range of $0.00 to $1.00M. The previous quarter’s sales results were $983.00K. SRZN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year SRZN has Performed in-line its overall industry.
SRZN Stock Forecast FAQ
What is SRZN’s average 12-month price target, according to analysts?
Based on analyst ratings, Surrozen’s 12-month average price target is 36.67.
What is SRZN’s upside potential, based on the analysts’ average price target?
Surrozen has 68.52% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is SRZN a Buy, Sell or Hold?
Surrozen has a consensus rating of Strong Buy which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is Surrozen’s price target?
The average price target for Surrozen is 36.67. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $42.00 ,the lowest forecast is $32.00. The average price target represents 68.52% Increase from the current price of $21.76.
What do analysts say about Surrozen?
Surrozen’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of SRZN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.